Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Epidemiology of Breast Cancer
Evelina Arzanova, Harvey N. Mayrovitz
Breast Cancer (2022), pp. 1-20
Open Access | Times Cited: 19

Showing 19 citing articles:

Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil’s public and private healthcare systems
Marcelo Antonini, André Mattar, Denise Joffily Pereira da Costa Pinheiro, et al.
The Breast (2025) Vol. 80, pp. 104417-104417
Open Access | Times Cited: 1
Molecular targets and therapeutic potential of baicalein: a review
Kavita Munjal, Yash Goel, Vinod Kumar Gauttam, et al.
Drug Target Insights (2024) Vol. 18, Iss. 1, pp. 30-46
Open Access | Times Cited: 6
Pioglitazone enhances cisplatin’s impact on triple-negative breast cancer: Role of PPARγ in cell apoptosis
Qamraa H. Alqahtani, Layla A. Al‐Kharashi, Hanaa N. Alajami, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 5, pp. 102059-102059
Open Access | Times Cited: 4
Anthracycline therapy induces an early decline of cardiac contractility in low-risk patients with breast cancer
Fabian Voß, Fabian Nienhaus, Saskia Pietrucha, et al.
Cardio-Oncology (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Unveiling the Therapeutic Potential: Okra-Derived Flavonoids in Breast Cancer Treatment
Anum Munir, Alan Janbey
Journal of Pharmaceutical Innovation (2025) Vol. 20, Iss. 1
Closed Access
The association between cirrhosis and outcomes among female patients undergoing surgery for breast cancer in Ontario: a population-based study
Manisha Jogendran, Johannes Flemming, Maja Djerboua, et al.
Breast Cancer Research and Treatment (2025)
Closed Access
Quality of Life in Breast Cancer Patients in Saudi Arabia: A Systematic Review
Faisal F Aljadani, Reem O Nughays, Ghaida Essa Alharbi, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 171-186
Open Access
Pertuzumab in Combination with Trastuzumab and Docetaxel as Adjuvant Doublet Therapy for HER2-Positive Breast Cancer: A Systematic Review
Ignacio Ventura, Nerea Pinilla Salcedo, Marcelino Pérez-Bermejo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1908-1908
Open Access
Multilevel analysis of undergoing clinical breast examination and its associated factors among mothers of reproductive age in Kenya: Kenyan Demographic and Health Survey 2022
Mohammed Seid Ali
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319183-e0319183
Open Access
Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention and Combination Therapies
Marisabel Mecca, Marzia Sichetti, Martina Giuseffi, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1883-1883
Open Access | Times Cited: 3
A Novel Decision Level Class-Wise Ensemble Method in Deep Learning for Automatic Multi-Class Classification of HER2 Breast Cancer Hematoxylin-Eosin Images
Pateel G.P., Kedarnath Senapati, Abhishek Kumar Pandey
IEEE Access (2024) Vol. 12, pp. 46093-46103
Closed Access | Times Cited: 2
Characteristics and transcriptional regulators of spontaneous epithelial–mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma
Huang‐Chun Lien, Hui‐Chieh Yu, Wen-Hsuan Yu, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Pathologic Complete Response Achieved in Early-Stage HER2-Positive Breast Cancer After Neoadjuvant Therapy With Trastuzumab and Chemotherapy vs. Trastuzumab, Chemotherapy, and Pertuzumab: A Systematic Review and Meta-Analysis of Clinical Trials
Faizan Fazal, Muhammad Nauman Bashir, Maham Leeza Adil, et al.
Cureus (2023)
Open Access | Times Cited: 3
AI-based density prediction for breast cancer prevention: can we measure mammographic density in just one breast?
Megan C. Perry, Stepan Romanov, Sacha J. Howell, et al.
Medical Imaging 2018: Computer-Aided Diagnosis (2024) Vol. 2023-07, pp. 10-10
Closed Access
Survival, Adhesion and Migration of Metastatic Breast Tumor Cells: Roles of Parvins (PARVA and PARVB)
Sadegh Dylami, Mohammad Kamalabadi‐Farahani, Vahid Kia, et al.
Research Square (Research Square) (2024)
Open Access
The burden of systemic therapy administration route in treating HER2-positive breast cancer (for patients, healthcare professionals, and healthcare system): a systematic literature review
Luciana Castro Garcia Landeiro, Tamie de Camargo Martins, Ruth Bartelli Grigolon, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Assessing the Factors Leading to Missed Breast Cancer Diagnoses in Mammography Among Pakistani Women: A Prospective Cross-Sectional Study
Mariam Malik, Rana Bilal Idrees, Sadia Anwar, et al.
Cureus (2024)
Open Access
The role of ethnic enclaves and neighborhood socioeconomic status in invasive breast cancer incidence rates among Asian American, Native Hawaiian, and Pacific Islander females in California
Alya Truong, Meg McKinley, Scarlett Lin Gomez, et al.
Cancer Causes & Control (2024)
Closed Access
The Importance of ERα/ERβ Ratio in Breast Cancer: Mitochondrial Function and Oxidative Stress
Pilar Roca, Jordi Oliver, Jorge Sastre‐Serra, et al.
InTech eBooks (2011)
Open Access | Times Cited: 1
Page 1

Scroll to top